Mary Greeley Cancer Case Conference

Ames, IA US
June 14, 2024

Target Audience

Limited to Mary Greeley Medical Center-approved providers, referring physicians, and other health care providers who practice and/or refer patients for care.


A multi-disciplinary clinical activity that serves to maintain, develop, or increase the knowledge, skills, professional performance, and relationships that a physician uses to provide services for patients, the public, or the profession. Participants will review the diagnostic procedures and treatment planning for patients with the following types of cancer: invasive lobular carcinoma, invasive ductal carcinoma, ductal carcinoma in situ, adenocarcinoma, and small cell carcinoma.


Jamie Weydert, MD
Pathologist, McFarland Clinic, Ames, IA

Professional Certifications

  • Diplomate, American Board of Pathology


  • MD: University of Iowa College of Medicine, Iowa City, IA
  • Residency: University of Iowa Hospitals and Clinics, Iowa City, IA
  • Fellowship: University of Iowa Hospitals and Clinics, Iowa City, IA
    • Surgical Pathology


None of the MGMC CME Committee members who planned this CME activity have any financial relationships to disclose regarding the content of the selected cases. Trisha Andersen, DO, Jamie Weydert, MD, and Christopher Johnson, MD, the Cancer Case Conference facilitators, disclose they have no financial relationships with a commercial entity producing healthcare-related products and/or services.

    Course summary
    Available credit: 
    • 1.00 AOA Category 2­A
    Course opens: 
    Course expires: 
    Event starts: 
    06/14/2024 - 7:00am CDT
    Event ends: 
    06/14/2024 - 8:00am CDT
    Mary Greeley Medical Center
    1111 Duff Avenue
    North Conference Room
    Ames, IA 50010
    United States

    Accreditation Statements

    • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.


    No ineligible company provided financial support for this continuing education activity. 


    Everyone in a position to control the content of this educational activity will disclose to the CME provider and attendees all relevant financial relationships with any commercial interest. The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.


    The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. 

    Available Credit

    • 1.00 AOA Category 2­A


    Please login or Create an Account to take this course.